A Form 4 filed on August 12, 2026 discloses that Mohsen Sohi, a director of STERIS plc (NYSE:STE), exercised a stock option for 4,058 ordinary shares and sold those shares on the same date, while also receiving new stock options and Career Restricted Stock Units on August 10, 2026.
Key Highlights
- Option exercise: Sohi exercised a Director Stock Option to acquire 4,058 ordinary shares at an exercise price of $86.23 per share on August 12, 2026.
- Share sale: Sohi disposed of 4,058 ordinary shares on August 12, 2026 at a weighted average price of $235.78 per share, with individual transaction prices ranging from $235.73 to $235.89.
- Post-transaction holdings: Following these transactions, Sohi directly held 24,305 ordinary shares.
- New stock options granted: On August 10, 2026, Sohi received 1,099 Director Stock Options at an exercise price of $238.91, fully vested immediately, expiring August 10, 2036.
- Career Restricted Stock Units: Sohi also received 1,229 Career Restricted Stock Units on August 10, 2026, fully vested immediately, bringing his total to 8,979 such units; settlement in ordinary shares occurs six months after cessation of Board service.
- Exercised option origin: According to the filing, the exercised option to purchase 4,058 shares at $86.23 was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019, subject to the same terms as the original option.
STERIS Director Exercises Legacy Option, Sells Shares, and Receives New Equity Grants
According to the filing, Mohsen Sohi is a director of STERIS plc, listed on the NYSE under the ticker STE. On August 12, 2026, he exercised a Director Stock Option covering 4,058 ordinary shares at an exercise price of $86.23 per share, using transaction code "M" (exercise of in-the-money or at-the-money derivative). The filing notes that this option originated from the redomiciliation of STERIS plc to Ireland in March 2019 and was issued in exchange for a prior option to purchase 4,058 ordinary shares in STERIS plc before the redomiciliation, subject to the same terms and conditions. The option had an expiration date of August 9, 2027 and, following the exercise, the remaining balance of this particular option is zero.
On the same date, Sohi disposed of 4,058 ordinary shares at a weighted average sale price of $235.78 per share, covering multiple transactions ranging from $235.73 to $235.89 per share, as disclosed in the filing's footnotes. After these two transactions, his direct beneficial ownership of ordinary shares stood at 24,305.
Separately, on August 10, 2026, Sohi received two new equity awards. First, 1,099 nonqualified Director Stock Options at an exercise price of $238.91, described as fully vested and exercisable immediately, with an expiration date of August 10, 2036. Second, 1,229 Career Restricted Stock Units were acquired, also fully vested immediately. The filing states that each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the director's Board service. Following this grant, Sohi's total Career Restricted Stock Units held stood at 8,979.
What Was Disclosed
The filing reports a director-level option exercise, an open-market share sale, and two new equity grants at STERIS plc on August 10 and August 12, 2026, with resulting direct ownership of 24,305 ordinary shares and 8,979 Career Restricted Stock Units.



Please wait processing your request...